HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...